Tennessee seeks to block inspection of drug used in Christa Pike's botched execution

Tennessee's attorney general has asked a court to block lawyers for Christa Pike, the death-row inmate who survived her own execution in September, from inspecting or testing the leftover lethal-injection drug used in the attempt. The state argues that letting Pike's legal team examine vials of pentobarbital or their labels could expose the identity of the drug's supplier, which Tennessee law shields from public disclosure.

The filing, made in Davidson County Chancery Court and reported Tuesday by CBS News and Fox News, asks Chancellor I'Ashea L. Myles to rescind part of an October 10 order that had required the Tennessee Department of Correction to preserve physical evidence from the botched execution and to let Pike's attorneys inspect, collect and test any pentobarbital left over from the attempt. The chancellor has not yet ruled on the request.

What the state is asking for

According to the court filing, an unnamed Department of Correction employee responsible for procuring the state's execution drug said in an affidavit that the supplier could be identified even from a redacted vial label, or simply by handling the vials themselves. The employee said a previous supplier cut off contact with the department in 2024 after its identity became public, and that the current supplier has warned it will do the same if exposed. Attorney General Jonathan Skrmetti's office wrote that "Pike's counsel and experts cannot be allowed to see, handle, or otherwise get the information on the leftover vials," warning that losing the supplier could leave the state unable to carry out lethal injections at all.

Pike's attorney, Luke Ihnen, rejected the idea that identifying the supplier is the point of the request. He said the defense wants to examine how the drug was labeled, stored, mixed, transported and handled — not who sold it — in order to understand what went wrong on the night of the execution.

"We still don't know exactly what happened that night."

That dispute sits inside a broader lawsuit in which Pike's lawyers have asked the court to preserve a specific list of items from the execution: the syringes used, drug packaging and lot numbers, catheters, intravenous lines and the gurney restraints, along with any residual drug traces for independent chemical analysis.

A failed execution that shocked death-penalty lawyers

Pike, 50, was convicted of the 1995 torture-killing of 19-year-old Colleen Slemmer, a fellow student at a Knoxville-area Job Corps center. She was 18 at the time of the crime and has spent three decades as the only woman on Tennessee's death row. Her execution, scheduled for September 30 after the U.S. Supreme Court lifted a last-minute stay, would have made her the first woman executed by the state in more than two centuries.

Instead, according to accounts from her attorneys and from the Death Penalty Information Center, Pike remained alive for more than an hour after the state began administering pentobarbital under its single-drug protocol, adopted in January 2025 after a multi-year review described in a Tennessee Department of Correction announcement. Execution staff reportedly tried roughly ten needles across both of her arms before administering two doses of the drug. Her lawyers say the pentobarbital likely never reached her bloodstream and instead pooled under her skin, causing visible burns and blistering, and that her veins may have ruptured during repeated attempts to place an IV line. She was hospitalized on a ventilator for several days, developed pneumonia and a blood clot, and has since returned to the Debra K. Johnson Rehabilitation Center, where she says she remains in constant pain.

The Death Penalty Information Center has said no other prisoner is known to have survived the administration of lethal-injection drugs in the modern history of American capital punishment. The episode was the second time in six months that a Tennessee execution team struggled badly to carry out a lethal injection; in May, officials spent more than an hour trying to establish an IV line on death-row inmate Tony Carruthers before Governor Bill Lee granted a one-year reprieve.

Fallout inside Tennessee's execution system

The failed attempt on Pike prompted immediate consequences. Correction Commissioner Frank Strada, who oversaw the execution, resigned afterward, and Lee named Christopher Hansen as interim commissioner. The governor ordered what he called a "comprehensive, third-party review" of the episode, retaining former U.S. Attorney Ed Stanton to examine whether the department followed its own protocol, and paused all executions scheduled for the remainder of 2026. Incoming Governor-elect Marsha Blackburn has said the state should explore alternative methods, including the electric chair, which Tennessee law already allows condemned inmates to choose.

The dispute over the leftover drug unfolds against years of litigation over how much Tennessee must disclose about its execution process. A separate federal challenge, Nichols v. Skrmetti, has pressed similar questions about the single-drug protocol's safety and the state's confidentiality shield for suppliers, while death-row prisoners brought an earlier chancery court complaint arguing the pentobarbital protocol carries an unconstitutional risk of a painful death. Tennessee's confidentiality statute, which bars public identification of anyone involved in supplying execution drugs or carrying out a death sentence, has repeatedly collided with prisoners' efforts to learn basic facts about the chemicals used against them.

Who is affected extends beyond Pike herself. The ruling Myles eventually issues will shape what evidence is available not only in Pike's case but potentially in future challenges brought by other death-row prisoners seeking to test Tennessee's execution drugs, and it will test how far a state's secrecy interest in protecting a compounding pharmacy can be stretched against a condemned prisoner's ability to show how an execution went wrong. Tennessee Department of Correction spokesperson Dorinda Carter has declined to comment, citing the pending litigation.

What happens next

No ruling has been issued on the state's motion to narrow the preservation order, and no new execution date has been set for Pike, who remains on death row while her attorneys separately press for her sentence to be commuted to life in prison. Stanton's independent review of the botched execution has not yet produced public findings. With executions paused through the end of 2026 and a new governor set to take office in January, the immediate fight over a handful of drug vials has become a proxy for a larger question hanging over the state's death penalty system: whether Tennessee can keep carrying out lethal injections at all without disclosing more about how they are supposed to work.